SPONSOR
Australasian Leukaemia and Lymphoma Group
Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: DLBCL - Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaHigh Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsDLBCL, Nos Genetic SubtypesHigh Grade B-Cell Lymphoma, Not Otherwise SpecifiedFollicular Large Cell Lymphoma, RelapsedFollicular Large Cell Lymphoma
Australasian Leukaemia and Lymphoma Group is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including DLBCL - Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, DLBCL, Nos Genetic Subtypes.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Australasian Leukaemia and Lymphoma Group
How many clinical trials has Australasian Leukaemia and Lymphoma Group sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Australasian Leukaemia and Lymphoma Group, of which 1 are actively recruiting participants. These trials cover conditions including DLBCL - Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Australasian Leukaemia and Lymphoma Group research focus on?
Australasian Leukaemia and Lymphoma Group clinical trials span DLBCL - Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, DLBCL, Nos Genetic Subtypes, High Grade B-Cell Lymphoma, Not Otherwise Specified, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Australasian Leukaemia and Lymphoma Group clinical trial?
To participate in a Australasian Leukaemia and Lymphoma Group trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Australasian Leukaemia and Lymphoma Group trials with current recruitment status updated daily.
Clinical Trials by Australasian Leukaemia and Lymphoma Group
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology